updat forecast estim oct
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research oct
estim oct
price data oct
rate updat oct
currenc amount express
busi strategi outlook
methodolog valu compani
busi strategi outlook
market sentiment turn stock three reason
slow organ growth compani matur recent
weak auto semiconductor chines market
litig risk relat pfa result bear maintain
model irretriev broken disagre
view gdp-plu busi attribut abil
remain ahead base suit innov product
by-product effort core materi
scienc compani firm legion engin improv everyday
product basic chemistri instanc
microrepl technolog around sinc
origin use overhead projector technolog
adapt multipl use case includ make
sign brighter reduc friction aerospac applic
recent develop vaccin deliveri
altern hypoderm needl
firm proprietari secret closely-held rare grant
licens yet technolog difficult imit result
typic charg price premium rel
market abil adapt technolog multipl use case
give addit economi scope reduc overal unit
cost evid superior gross margin
expect near-term headwind continu
believ compani grow top line organ
next five year anoth point acquisit
recent acquisit workflow solut provid mmodal
neg wound care solut provid acel believ firm
capit stabl ever-grow healthcar market
healthcar benefit multipl posit secular trend includ
age popul greater access care well rise
incid chronic diseas surgic procedur believ
rest portfolio also benefit rise industri
urban
trend final survey prior
environment product liabil case believ stock
price bake overli pessimist litig risk
valuat summari forecast
financi summari forecast
historical/forecast data sourc morningstar estim may reflect adjust
multi-national conglomer oper sinc
known minnesota mine manufactur compani
well-known research develop laboratori firm
leverag scienc technolog across multipl product categori
organ four busi segment safeti
industri transport electron health care consum
compani revenu come outsid unit state
safeti industri segment constitut firm net sale
mani compani product touch concern varieti
consum end market
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oct announc complet
acquisit acel enterpris valu
billion repres largest acquisit ever made
took opportun revisit assumpt
close scrutin divis
resegment five four segment earlier year
reduc fair valu
reduct rais uncertainti rate medium
yet retain wide moat stabl trend exemplari
even bounc oct still believ
stock trade discount intrins valu diversifi
industri space bargain note
price gdp-plu busi doesnt
offer much way top-lin growth even like
name specul upcom recess
defens stock
view market tradit valu like
consum healthcar stock industri exposur
industri stock typic trade somewher
time time next month ep
tradit trade upper end rang typic
time great recess
stock perform well abl retool signific
portion manufactur oper benefit
subsequ econom recoveri think market pay
certainti right earn premium
junctur market discount stock
follow three reason slow organ growth
compani matur recent weak automot
semiconductor chines market environment
product liabil litig risk relat pfa
promin bear go far maintain model
irretriev broken disagre industri
signific short-cycl exposur order place
immedi fill like
seen stock price take signific hit
recent contrast signific aerospac
exposur like honeywel unit
fortuit posit see upward support
guidanc even believ long-term
competit advantag intact
phenomenon play take
core materi scienc compani firm
legion scientist engin improv everyday product
basic chemistri cite sever exampl
microrepl technolog akin cover larg
sheet surfac like plastic thousand microscop
pyramid precis sculpt uniform technolog
proprietari exist sinc
use overhead projector asid improv
luminos reflect object use highway
safeti well reduc friction aerospac
marin applic technolog use
vaccin deliveri tool patient afraid
trial therapeut cancer vaccin directli
skin rel painless manner surfac size
dime
product give firmer foothold grow
grow geriatr popul rise incid surgic
procedur greater access care develop economi
well rise incid chronic diseas like asthma
diabet
microrepl technolog extract blood measur
collect scientif
breakthrough translat strong competit posit
market think grow mid-singl digit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
overhang stock current estim billion
includ total product environment liabil
use sever methodolog uncov number
includ estim extent liabil base
pend suit use compar histor preced
major environment product liabil suit well
percent market capit appel judg
occasion employ guidepost
one thing think market miss amount juri
award necessarili amount ultim award
plaintiff appeal recoveri usual cent
dollar coupl point comparison weve use
billion anadarko environment settlement
well product liabil settlement
howev balanc consider fact
alreadi settl million suit home
state minnesota well present valu assumpt
note million reserv cours
also reiter view acel rel value-
neutral acquisit ad fair valu
estim client may toggl whether includ
acquisit model mirror consensu practic
exclud acquisit bake acel think
stock worth time adjust ep
number lead us conclud acquisit
made sens strateg versu financi
potenti upsid unannounc revenu synergi
first compani maintain level
invest hair sale yet believ
maintain best-in-class return research
capit gross profit prior year spend nearli
line histor figur believ larg part
success rate testament model wherebi
sale gener spec-in order lastli
person protect equip ppe market
anoth busi believ offer investor high
growth high impact medium term think
annual grow busi given greater
awar concern employe health safeti asid
posit secular trend like rise construct
govern agenc like occup safeti
administr promulg strict
regard use ppe mani global counterpart
follow suit given high risk worker safeti
auto metal manufactur like posit
given abil meet market demand innov
product balanc comfort light weight premium
materi product like chemic protect coveral
instanc need qualiti
ultim affect worker safeti product
dont think market concern potenti
pfa liabil valid least extent bake
stock price estim mid-teen
billion believ lower single-digit billion dollar
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
compani consist increas dividend
year feat accomplish four diversifi
industri firm estim pay-out ratio
exceed proport adjust ep
exce industri averag typic
think demonstr commit return cash
sharehold
final point privileg welcom
cfo nick gangestad firesid chat behind
moat confer thursday nov
final present confer take place
pm global headquart chicago
adhes current line-up
forecast firm increasingli direct
capit expenditur spend toward divis
conclud higher-grow portion ppe
market instanc driven grow concern
surround employe health safeti tandem new
regul believ firm well-posit
space given materi scienc core compet ppe
market demand innov product balanc comfort
aesthet lighter fabric well premium qualiti
protect materi rise manufactur construct
product develop economi apac region
propel growth
reseg model take deeper dive
underli fundament litig exposur
acquisit acel lower fair valu estim
per share previous
even exercis give us greater confid
four-star rate reiter view stock
trade slight discount space
pound-the-t bargain assess acel bring
us conclud acquisit add
underli valu valu stock time
adjust ep hair time adjust ep
note histor stock trade time
time adjust next twelv month ep -- premium
rel diversifi industri typic trade
time time earn
next five year believ increas
revenu organ basi compound-annual-growth-rate
bake acquisit acel
influenti growth driver observ includ
person protect equip market growth
global medic dress medic softwar market
respect well traffic safeti
medic solut project rise incid wound
infect around world diabet chronic diseas
rise asid legaci strength
acquisit acel also provid much
stronger foot neg wound care market rise
geriatr popul anoth industri tailwind
portion health segment benefit trend
toward value-bas care work flow solut
doctor improv document patient care
rais uncertainti rate medium low
given somewhat lower degre confid rang
potenti intrins valu compani
bull-cas scenario fair valu estim rise
per share top-lin growth nearli compound-annual-growth-rate
oper margin improv well basi
point level assumpt
bull case relat faster growth market
product portfolio expos base assumpt
strength firm portfolio respons
custom instanc firm benefit addit
exposur faster grow portion specif
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
healthcar also afford firm addit oper
profit high-margin segment
margin assumpt credit mani manag
initi drive expand margin includ addit
benefit deriv region servic center common
enterpris resourc plan platform well addit
lean measur drive oper effici return
research capit rise nearli gross profit
everi dollar spent
bear case relat
bear-cas scenario fair valu estim drop
per share top-lin growth rise nearli
compound-annual-growth-rate manag organ top-lin guidanc
oper margin stubbornli maintain toward
midpoint histor perform
competit broad-bas market weak throughout
product portfolio effect competit
compress oper margin forc cut price
maintain net sale remain competit key
end market bear-cas scenario also assum
mani manag initi yield addit
oper effici fail bear fruit final return
research capit fall gross profit
everi dollar spent
believ wide econom moat base
intang asset cost advantag diversifi
industri space believ central leverag
core compet pivot build endur
competit advantag innov powerhous
leverag platform across multipl product
categori byproduct includ patent brand
proprietari technolog
firm spend net sale compar
median global innov
median diversifi industri firm
mani firm say innov yield
invest quantifi superior return
research capit outpac name top
innov compani name boston
consult group everi dollar spent
yield gross profit versu
averag top case even everi name
list technolog sector aggreg
accord statista technolog sector account
nearli global spend compar
entir industri sector three-year cycl
return research capit outpac firm
top except bcg number-on rank firm
think testament busi model
emphas effect commerci two
process customer-inspir innov focus
custom spec-in revenu insight
innov tradit market-driven approach
revenu firm receiv
difficult-to-repl intang asset cultiv
centuri worth oper addit
benefit effici elimin program
bear littl probabl commerci
altern acceler potenti high
impact high probabl success also
firm senior engin time unbudget work
new idea project independ normal
strong brand high share mind includ
scotch-brit ace bandag mani brand
command premium price exampl
standard yellow post-it note typic sell price
premium compar gener counterpart
believ consum will pay extra premium
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
associ product given reput
qualiti well superior efficaci overal firm
steadili risen brand valu recent year climb
interbrand top best global
ahead well-known brand like nestl
colgat product touch concern
nearli everi industri firm portfolio overli
depend singl product categori
increas confid long-run return invest
addit throughout histori firm benefit
global patent award accord
search patent trademark offic
award patent sinc
believ current patent portfolio exce carri
amount million list balanc sheet
account permit write
intang asset belief anchor firm
proven consist abil use asset gener
excess return think major
recent patent portfolio util
patent base data intellectu properti owner
associ qualifi design invent
must novel new non-obvi given compar
higher hurdl obtain util patent offer
advantag design patent given intellectu
properti protect around invent function
also protect mani differ variat product
singl approv file think complex
disrupt technolog reflect strength intang
asset moat sourc case microrepl
technolog use road sign grinder overhead
gross margin sale versu
median compar peer firm share
resourc provid economi scope
abras technolog affect industri construct
home improv retail well automot
aftermarket collis repair firm adhes also
use wide rang applic scotch tape
post-it note tegaderm medic dress
emphasi region suppli chain reduc
complex manufactur process allow
shorter suppli chain fewer stock-keep unit
common process ultim translat diminish
demand work capit greater capit effici
drive unit cost improv custom experi
fewer back order cost custom servic
benefit amplifi common enterpris resourc
plan platform
function across suppli chain procur
addit benefit get
geograph proxim custom firm also
deriv economi scale manag suppli chain
across broader geographi vertic integr
firm manufactur mani raw materi lower
cost competitor moreov plant around
world anchor site time
larger typic plant larger plant
averag product smaller plant
tend drive inventori turn averag faster
phenomenon hold true firm distribut
center faster smaller local
technolog platform manufactur scale
allow achiev lowest unit cost
categori compet result enjoy
calcul period
achiev increment return tangibl asset
least past year return
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
improv includ benefit yield averag
lean sigma project averag lean
project yield benefit
aggreg compani deriv estim
billion save lean project think
testament effect lean
sigma program howev attribut margin benefit
process oper excel oppos
anyth uniqu inimit lean process
believ firm cost advantag moat sourc stabl
capit includ goodwil doubl
estim cost capit even year
compani endur neg sale growth even
worst past year still manag earn return
includ goodwil clear weight averag cost
capit hurdl time result
high degre confid continu
produc excess return least next year
view moat trend stabl quantit
five-year forecast adjust return invest capit
modestli line five-year
histor adjust return invest capit
net goodwil intang moat sourc firm
proprietari technolog continu support
consist spend approach
revenu sever year variou five-year cycl
return research capit rel constant
fluctuat gross profit everi
dollar spent believ posit option
roic-increas opportun greater licens
intellectu properti particularli electron
busi lack organ revenu growth
consist divis compani past
electron materi
solut licens deal offer advantag
incur addit cost ip develop
nevertheless believ qualit chang
moat bar evid initi
still see intang moat sourc stabl
cost advantag moat sourc firm expand
gross oper margin recent year said
believ mani improv uniqu
admiss entir industri benefit
sever raw materi tailwind tangibl
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
continu emphas innov keep
competitor away gener level
spend total six percentag net
oth firm continu benefit share
technolog platform applic multipl
use case technolog allow charg premium
product also bring unit cost
like profit segment geographi
expos faster-grow portion global
allow handili outperform
owhil earn return doubl
cost capit year firm effort
struggl gener addit sale
challeng automot semiconductor
market custom inventori destock
econom slowdown china
struggl attract retain best
brightest scientist engin believ
futur gener increasingli gravit toward
technolog sector
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
view well capit firm anticip
materi increas leverag billion billion
optim capit structur eye toward
opportun acquisit acel firm
rapidli approach lower end rang
expect net debt ebitda remain time
firm close acquisit acel oct
said concern debt
level given abil grow earn mild recess
importantli abil convert nearli
earn free cash flow mid moreov
expect net debt/ebitda return
histor time norm expect ratio
somewhat trail length explicit forecast
firm interest coverag ratio ebit/net interest
expens basi bake incom pension
stand time suggest plenti firepow
servic interest-bear liabil
expos sever risk includ slow organ
growth compani matur end market weak
product execut risk relat recent acquisit
mmodal acel well market reject
new product introduct crucial given
compani emphasi innov recent
litig product risk think
critic risk relat pfa class
organ fluoride-bas compound creat
compound easili broken
natur found water suppli portion
unit state europ origin manufactur
everyday product like non-stick pan fire-retard
materi voluntarili phase compani
process began earli nevertheless
firm settlement environment suit includ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
home state minnesota amount
million versu suit origin sought pay-out
billion offic state attorney gener firm
recent reserv million five manufactur site
includ three unit state two europ
howev point reserv account
product liabil risk signific given
associ higher cholesterol among expos
popul limit associ low birth weight
immunolog effect said think market
over-aggress bake litig liabil
exce like outcom guess market assess
mid-teen billion dollar penalti howev survey
prior environment product liabil case lead us
assum low- mid-singl digit billion-dollar liabil
far like
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
repres date owner name posit common share held report holder issuer
capit research manag compani
share
fund
share
fund
assign manag exemplari stewardship rate
michael roman becam ceo juli take
well-regard predecessor ing thulin
year prior capac chief oper
offic execut vice presid roman purview
firm intern oper well
then-fiv busi segment serv roman
head industri busi group
doubt roman materi pivot playbook
laid roadmap particularli sinc
intim involv strateg plan process
past roman emphas growth
organ invest acquisit continu
leverag insight around critic custom product
development-a strategi like view recent
re-affirmed investor day roman
present specif mention build
success sinc like roman focus
strateg prioriti toward health care
portion portfolio benefit infrastructur
spend like person protect equip market
 capit expenditur spend
approxim sale respect
think increasingli reli upon augment
organ growth one acquisit view posit
acquisit scott safeti roman oversaw
integr busi gain busi
combin lead person safeti portfolio
acquisit acel largest ever
optic cheap improv posit
advanc wound care market opportun
addit revenu synergi deal
model took deeper look acquisit
estim deal neglig valu accret
ad fair valu estim
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
preserv mid-cycle nearli three
time cost capit
final recogn pfa somewhat tarnish
brand promis commonli associ
sustain practic point compani
taken number action address underli issu
includ clean-up initi settl
minnesota attorney gener voluntari phase
use chemic everyday product
despit five guidanc cut sinc roman instal
pfas-rel risk well pay high price deal
carri consider execut risk maintain
exemplari stewardship rate firm base
long-stand reput excel first firm
improv free cash flow convers thulin
instal percent
recent year even thulin increas firm
spend percentag net sale tenur
free cash flow eb overli
concern model bounc back head next
year -- expect convers exceed
remain next five year
second import manag thulin
increas firm pay-out ratio begin
tenur left roman
continu pay gener dividend pay-out ratio
earn expect pay-out ratio
rise basi top end
rang multi-industri peer typic pay
earn compar healthcar firm
typic pay earn
appreci oper steadi low-growth
industri prefer return capit sharehold
overpay acquisit buy back share less
attract price exampl immedi follow
fourth-quart result instanc
prefer manag pay increas dividend thulin
also demonstr willing aggress monitor
cost go far cancel firm annual meet
product expo interest sharehold
also appreci thulin commit preserv
polici unalloc assign
senior engin well reluct impos
much process cost innov believ
commit remain steadfast firm
roman leadership expect firm come close
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
oct announc complet
acquisit acel enterpris valu
billion repres largest acquisit ever made
took opportun revisit assumpt
close scrutin divis
resegment five four segment earlier year
reduc fair valu
reduct rais uncertainti rate medium
yet retain wide moat stabl trend exemplari
even bounc oct still believ
stock trade discount intrins valu diversifi
industri space bargain note
price gdp-plu busi doesnt
offer much way top-lin growth even like
name specul upcom recess
defens stock
view market tradit valu like
consum healthcar stock industri exposur
industri stock typic trade somewher
time time next month ep
tradit trade upper end rang typic
time great recess
stock perform well abl retool signific
portion manufactur oper benefit
subsequ econom recoveri think market pay
certainti right earn premium
junctur market discount stock
follow three reason slow organ growth
compani matur recent weak automot
semiconductor chines market environment
product liabil litig risk relat pfa
promin bear go far maintain model
irretriev broken disagre industri
signific short-cycl exposur order place
immedi fill like
seen stock price take signific hit
recent contrast signific aerospac
exposur like honeywel unit
fortuit posit see upward support
guidanc even believ long-term
competit advantag intact
phenomenon play take
core materi scienc compani firm
legion scientist engin improv everyday product
basic chemistri cite sever exampl
microrepl technolog akin cover larg
sheet surfac like plastic thousand microscop
pyramid precis sculpt uniform technolog
proprietari exist sinc
use overhead projector asid improv
luminos reflect object use highway
safeti well reduc friction aerospac
marin applic technolog use
vaccin deliveri tool patient afraid
trial therapeut cancer vaccin directli
skin rel painless manner surfac size
dime
product give firmer foothold grow
grow geriatr popul rise incid surgic
procedur greater access care develop economi
well rise incid chronic diseas like asthma
diabet
microrepl technolog extract blood measur
collect scientif
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
breakthrough translat strong competit posit
market think grow mid-singl digit
person protect equip ppe market
anoth busi believ offer investor high
growth high impact medium term think
annual grow busi given greater
awar concern employe health safeti asid
posit secular trend like rise construct
govern agenc like occup safeti
administr promulg strict
regard use ppe mani global counterpart
follow suit given high risk worker safeti
auto metal manufactur like posit
given abil meet market demand innov
product balanc comfort light weight premium
materi product like chemic protect coveral
instanc need qualiti
ultim affect worker safeti product
dont think market concern potenti
pfa liabil valid least extent bake
stock price estim mid-teen
billion believ lower single-digit billion dollar
overhang stock current estim billion
includ total product environment liabil
use sever methodolog uncov number
includ estim extent liabil base
pend suit use compar histor preced
major environment product liabil suit well
percent market capit appel judg
occasion employ guidepost
billion anadarko environment settlement
well product liabil settlement
howev balanc consider fact
alreadi settl million suit home
state minnesota well present valu assumpt
note million reserv cours
also reiter view acel rel value-
neutral acquisit ad fair valu
estim client may toggl whether includ
acquisit model mirror consensu practic
exclud acquisit bake acel think
stock worth time adjust ep
number lead us conclud acquisit
made sens strateg versu financi
potenti upsid unannounc revenu synergi
first compani maintain level
invest hair sale yet believ
maintain best-in-class return research
capit gross profit prior year spend nearli
line histor figur believ larg part
success rate testament model wherebi
sale gener spec-in order lastli
compani consist increas dividend
year feat accomplish four diversifi
industri firm estim pay-out ratio
exceed proport adjust ep
exce industri averag typic
think demonstr commit return cash
sharehold
one thing think market miss amount juri
award necessarili amount ultim award
plaintiff appeal recoveri usual cent
dollar coupl point comparison weve use
final point privileg welcom
cfo nick gangestad firesid chat behind
moat confer thursday nov
final present confer take place
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
pm global headquart chicago
manag weather near-term headwind
face
quarter sale billion year year
rel flat organ local-curr basi neg
year year underli margin exclud
impact restructur rose basi
point welcom develop given
difficult comp last year second quarter amid boost
custom demand ahead enterpris resourc
plan roll-out compani also maintain guidanc
first time recent memori suggest compani
adapt recent weak automot
semiconductor chines market well effect
custom inventori destock even noth
latest result alter fundament view firm
rais fair valu estim
howev entir due time valu money
made chang model time
sale recogn acel acquisit
expect close fourth quarter
neglig impact fair valu estim fair valu
estim impli forward multipl
adjust ep estim
midpoint manag full year
adjust ep guidanc rang note
push time sale relat acel
manag guidanc never bake acquisit
despit recent organ top-lin growth headwind
still expect organ local currenc growth full
year mid-point manag
guidanc small boost mmodal report
turn firm segment first quarterli
result use firm recent re-segment
reduc portfolio five segment four
result pleas see health care sale grow
includ organ basi posit organ
sale result seen healthcar inform system
medic solut food safeti oral care wed like
continu see strong organ result segment
line mid-single-digit top-lin assumpt
encouragingli manag highlight call
despit overal weak china health care organ top
line rose high-singl digit region
safeti industri top line grew year
year organ result fell base declin industri
adhes tape electr market abras closur
mask well automot aftermarket
still expect continu weak automot
electron market throughout rest year
continu impact top-lin perform
segment manag guidanc also point toward
organ sale declin transport
organ agre analysi project full-
year organ sale declin neg new
segment compani make portfolio move
like includ divestitur ga detect
part scott safeti acquisit think
import compani focu high-valu portion
person safeti market believ leverag
 lab creat differenti product price
premium rest market phenomenon see
throughout rest busi
final compani also provid slight updat pfa
commit sustain practic note
adjust ep retain manag practic
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
adjust ep estim contempl
impact project pfa oblig firm
may due difficult assess time potenti
settlement even point impact
project oblig minim fair valu
less per share current concern
dont impact thesi believ
oblig coupl slow organ growth could
somewhat constrain cash surmis would
somewhat limit buyback potenti under-valued share
futur given compani state prefer
increas dividend line earn time
overal share trade discount
underli valu longer see appreci
discount junctur
slightli lower fve evalu
take closer look pfa exposur slightli
lower fair valu estim firm
reserv pfa liabil current total million
took first quarter importantli howev
reserv sole manufactur liabil face
directli facil specif three site
unit state two europ reserv
includ product liabil exposur estim
much greater reserv
view exposur product side
billion base scenario effect brought
fair valu estim off-set boost
time valu money bull case number fall
billion bear case rise billion also
amort oblig cours explicit
forecast less final year would calcul valu
perpetu adjust oblig part
adjust ep assumpt bottom line believ
lot reaction stock price base irrat
fear oblig could total ten billion dollar
dont agre base avail evid
calcul exposur base inform
latest file first-quart includ number
jurisdict litig pend well
estim total respons base
minnesota settlement pfa famili
manmad fluorin organ chemic use
sinc stain-repel scotchgard
firm also sold pfa compani make teflon
firefight foam among applic
strong molecular bond found water suppli
understand dont break natur
phase compound
assum highest
concentr exposur howev home
state minnesota settl state
attorney gener million public polici
perspect also dont believ extent
settlement mirror minnesota found
state stock price trade price
think share would offer attract
risk/reward wide-moat enterpris provid long-term
investor could stomach short-term volatil hedg
largest deal advanc wound
may wide-moat rate announc far largest
deal ever advanc wound care provid acel
review deal
impact re-
segment incorpor first-quart result
guidanc lower fair valu estim per share
previous primari driver lower
valuat manag recent outlook organ
growth throughout rest year markedli
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
fell near-term expect nevertheless
intrins valuat perspect remind investor
saw previous stock overvalu
ralli prior first-quart earn believ
long-term thesi stock remain intact
continu retain wide-moat stabl trend exemplari
stewardship low uncertainti rate stock price
think stock trade within realm
reason term price fair valu ratio
net synergi deal seem expens side
us time unadjust ebitda model deal
slightli valu dilut akin market reaction today
saw stock drop throughout trade
day believ deal rational highli depend
manag abil extract ambiti cost synergi
target revenu cours three
year sever concern daunt task
first manag acknowledg slow react
market headwind prompt lower guidanc
short-cycl busi inher hard predict
earli clue slowdown trickl
china well automot electron rest
coverag second manag undergo
restructur program recent announc
also juggl sever lawsuit relat pfa
asbesto litig relat respir
overli concern develop
yet think theyr greater initi appreci
continu monitor third acel
set ipo coupl week ago suggest
will pay even higher multipl top
econom cycl -- gener formula creat long-
term sharehold valu fourth billion enterpris
valu includ agre assum roughli billion
debt doubl previou larg deal
billion capit safeti fifth organ growth
slow compani dump use new
vital index base logic fruit
spend would show organ top-lin result
pull back slightli spend rel
silver bullet figur chanc theyv spent
less also unfortun side effect earn
less metric use track return research
capit gross profit prior-year spend last year
metric dip compar last year
medium-term expect
nevertheless think issu short term
normal ebb flow still see moat around
busi intact compar lower price target
estim see consensu
firm intang asset moat doesnt offer greater
inflat annual price increas gener price
consum product competitor last
year abl off-set inflat price without
sacrif volum still maintain premium
sixth recent credit outlook downgrad
neg one three rate agenc
debt doesnt overli concern us higher level
weve seen histor amid headwind final
weve thought histor prefer organ
growth large-scal regular part
firm dna acel moreov doesnt appear
grow materi faster long-term
segment expect organ acel
posit side ledger howev like
compani focus acquir target fit
firm strateg rational doesnt appear take
far outsid core compent acel
portfolio seem complement offer health
segment tandem safeti portfolio remain
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
larg part long-term thesi stock expect
strong secular trend acel exposur
 market babi boomer popul age
expect benefit rise incid
chronic diseas like diabet well surgic
procedur word glad fish
right pond could wrong acknowledg
manag could extract valu see
slightli rich deal prefer sit sidelin
mike roman first challeng helm apr
wide-moat first-quart earn noth short
swing miss weve longtim fan
compani uniqu corpor cultur even think
declin stock market price april
larg forese least junctur futur
indic rate april
announc around time last year fair valu
estim repres lowest price target consensu
estim built bottom-up analysi busi
subseg simpli couldnt understand
constitu busi would support stock price
april close particularli amid markedli slow top-
line organ growth end market signific
amount exposur slow automot
electron end market well china compar
peer entir asia-pacif region repres nearli one
third sale
roman stewardship moreov compani
walk back guidanc sever occas five
count that one year time
understand short-cycl busi inher hard
predict lack massiv backlog long-cycl
busi honeywel count
busi exampl think prudenc could
spare irrat rise stock price april
announc howev expect modestli
reduc fair valu estim despit view
continu near-term headwind still
retain wide moat low uncertainti stabl trend
quarter total sale billion
year year reduct neg organ
fell basi point year year
adjust signific litig charg flow
biggest sore spot automot
similarli vex rockwel autom earlier oem
channel year year driven first quarter
global car
contribut automot oem channel well
electric-rel busi year year
manag also report china hong kong saw
top line year year tough comp
last year saw sale rise year year
result pressur previous announc
re-segment earlier quarter see
segment reduc four five segment
includ health safeti industri transport
electron consum contemporan
april announc compani announc
undergo restructur wit broad-bas
reduct job global restructur
mean take million charg
accord manag expect see annual
save million million million
year alon think restructur signal two
thing go forward continu struggl
grow materi faster global organ basi
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
reserv review sourc
minimum anticip slog given resolut
depend state-by-st approach
given sheer size restructur repres mike
roman first real test ceo
even think wide moat around busi
thesi remain intact assur ceo mike
roman comment call said
invest would say innov broadli
fundament promis investor
firm preserv intang asset base premium
price product rel competitor
give take think imper continu
spend sale research develop
high return capit afford opportun
miss
exampl one area near-term poor perform
concern drug deliveri health
segment remain fundament part thesi
consum busi still see high growth
given rise surgic procedur chronic ill
like diabet particularli babi boomer popul
age drug deliveri specif project-bas busi
line work solut may target rise
pulmonari diseas around world lumpi busi
growth consist wed rather invest
money within moat protect despit year-over-year
one area keep long-term eye howev
effect litig relat pfa respir
pop increasingli radar speak
media sourc review firm file
firm promis addit disclosur main
concern pfa litig particularli repres
common fact pattern million settlement
paid minnesota last year risk contagion
form far lawsuit spread state
reserv judgment test adequaci
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
